[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS60208940A - Separation and purification of long-chain saturated acid - Google Patents

Separation and purification of long-chain saturated acid

Info

Publication number
JPS60208940A
JPS60208940A JP59063892A JP6389284A JPS60208940A JP S60208940 A JPS60208940 A JP S60208940A JP 59063892 A JP59063892 A JP 59063892A JP 6389284 A JP6389284 A JP 6389284A JP S60208940 A JPS60208940 A JP S60208940A
Authority
JP
Japan
Prior art keywords
long
unsaturated fatty
solvent
eluent
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59063892A
Other languages
Japanese (ja)
Inventor
Soichiro Takeuchi
竹内 荘一郎
Keizaburo Miki
敬三郎 三木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
Original Assignee
Nippon Zeon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zeon Co Ltd filed Critical Nippon Zeon Co Ltd
Priority to JP59063892A priority Critical patent/JPS60208940A/en
Publication of JPS60208940A publication Critical patent/JPS60208940A/en
Pending legal-status Critical Current

Links

Landscapes

  • Fats And Perfumes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:Long-chain unsaturated fatty acids are separated from a mixture thereof with long chain fatty acids by reverse phase partition chromatography using a specific organic solvent as an eluent to collect long-chain unsaturated fatty acids efficiently through simple operations. CONSTITUTION:Long-chain fatty acid mixture is subjected to reverse phase partition chromatography using, as an eluent, an organis solvent with a solubility parameter of 11-20 to separate long-chain unsaturated fatty acids such as eicosapentaenoic acid or docosahexaenoic acid, which are used as a starting materials of prostaglandin. As an eluent, is cited acetonitrile, methanol, ethanol, N-methylformamide or formamide. Methanol is most preferred, because it has good separation activity and easiness in solvent removal. The solvent is previously refluxed to eliminate oxygen whereby the formation of peroxides can be avoided.

Description

【発明の詳細な説明】 本発明は種々の炭素数の長鎖口1j肪酸酸化物の混合物
から長鎖不飽和脂肪酸化合物を分1111:精製する方
法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for purifying long chain unsaturated fatty acid compounds from a mixture of long chain fatty acid oxides of various carbon numbers.

エイコザペンタエン酸C以下、 EPAと称する)やド
コサヘギサエン醐(以下、 DHAと称する)のような
長6礎の不飽和脂肪0は、主にイワシ、サケ、タラなど
のごとき魚の体内に他の長fKJ %肪酸とともにグリ
セライドの形で含有されており、生体内において脳梗塞
や心筋梗塞等の血栓性の疾患を防ぐ作用をもつ物質とし
て知られている。また近年、EPAはアラキドン酸やジ
ホモr−サルン酸とともにプロスタグランジンの原料と
しても注目されており、薬理作用の研究が盛んに行なわ
れるようになっている。かかる事情から、昨今、高純度
のEPAやDHAの工業的製法の開発が待たれでいる。
Unsaturated fats such as eicosapentaenoic acid C (hereinafter referred to as EPA) and docosahegisaenoic acid (hereinafter referred to as DHA) are mainly found in the bodies of fish such as sardines, salmon, and cod. It is contained in the form of glyceride along with long fKJ% fatty acids, and is known as a substance that has the effect of preventing thrombotic diseases such as cerebral infarction and myocardial infarction in vivo. In recent years, EPA has also attracted attention as a raw material for prostaglandins, along with arachidonic acid and dihomo r-salunic acid, and research on its pharmacological effects has become active. Under these circumstances, the development of an industrial method for producing highly purified EPA and DHA has been awaited recently.

従来、魚油等に存在するEPAやDHAを分離精製する
方法として、まずグリセライドをメタノールヤ−11−
タンー#等の低級アルコールのニス7 ルK 変換した
後、蒸留し、さらに尿素包接処理による濃縮を行う方法
が知られている(例えば特開昭58−8037号)。し
かし、この方法で得られるEPAやDHAのエステルの
純度は、高々20〜60%程度であり、沸点の近いもの
の混合物のためにそれ以上の高純度化は困難である。
Conventionally, as a method for separating and refining EPA and DHA present in fish oil, etc., glyceride was first processed in a methanol tank.
A method is known in which a lower alcohol such as Tan-# is converted into a varnish, distilled, and further concentrated by urea inclusion treatment (for example, JP-A-58-8037). However, the purity of the esters of EPA and DHA obtained by this method is about 20 to 60% at most, and it is difficult to achieve higher purity because they are a mixture of substances with similar boiling points.

また高純度のDPA JpDHAを得る手法として逆相
クロマトグラフィーを用いる方法も検討されておリ、ア
ルギル基結合シリカの充填カラムを用いてアセトン、メ
タノール及び水の混合液を溶離液とする方法(特開昭5
8−88339号)、ンリカゲル系または合成高分子系
逆相分配クロマトカラムを使用して水、低級アルコール
及び脂肪族ケトン。
In addition, a method using reversed phase chromatography is being considered as a method for obtaining highly pure DPA JpDHA. Kaisho 5
8-88339), water, lower alcohols, and aliphatic ketones using a gel-based or synthetic polymer-based reversed-phase partition chromatography column.

酢酸エチルもしくはアセトニトリルより成る群から選択
される少なくとも1種の成分の混合液を溶1lIi液と
する方法(特開昭58−109444号)が提案されて
いる。しかし、これらの方法では水を含む溶離液を用い
ているので試料の溶解度が小ざく、希薄な試料溶液を時
間をかけて仕込むかまたは有機溶々11.のみの濃厚溶
液として仕込んでカラム上で析出した試料を人足の溶媒
を流し絖けて徐々に溶かさねばならないという欠点があ
る。
A method has been proposed in which the solution is a mixture of at least one component selected from the group consisting of ethyl acetate or acetonitrile (Japanese Patent Laid-Open No. 109444/1983). However, since these methods use an eluent containing water, the solubility of the sample is low, and it is necessary to prepare a dilute sample solution over time or to prepare an organic solution. The drawback is that the sample, which is prepared as a concentrated solution and deposited on the column, must be gradually dissolved by manually pouring solvent over the column.

またI):J画した留分から目的成分を回収するために
は、水可溶の有機溶媒を揮散させた後、水に不溶な有機
溶媒を加えて目的成分を抽出し、しかる後、油水分離し
て有機溶媒を蒸散させる方法を採るか、または分画され
た留分なそのまま真空乾煉にかけて全溶媒を飛ばす方法
を行うかする必要がある。しかるに前者は複雑な工程で
あり、後者はEP人やDMAが熱に弱いため低温で処理
せねばならず、共に工業的には不経済な方法である。
In addition, in order to recover the target component from the fraction I):J, after volatilizing the water-soluble organic solvent, add a water-insoluble organic solvent to extract the target component, and then oil-water separation. It is necessary to either evaporate the organic solvent by evaporating the organic solvent, or to evaporate all the solvent by directly subjecting the fractionated fraction to vacuum drying. However, the former is a complicated process, and the latter requires treatment at low temperatures because EP and DMA are sensitive to heat, and both are industrially uneconomical methods.

そこで本発明者らは、逆相クロマトグラフィーを応用す
る方法のかかる欠点を改良すべく鋭意研究を行った結果
、特定な溶離液を用いることが有を 効なことを思い出し、本発明を完成するに到った。・か
くして本発明によれば、長鎖不飽和脂肪酸化合物を含む
長鎖脂肪酸化合物の混合物から逆相分配クロマトグラフ
ィー用担体を充填したカラムを用いて逆相分配クロマト
グラフィーを行うことにより目的とする長鎖不飽和脂肪
酸化合物を分離精製する方法において、溶離液として溶
解度パラメーターが11〜20の有機溶剤を用いること
を特徴とする長鎖不飽和脂肪酸化合物の分離精製法が提
供される。
Therefore, the present inventors conducted intensive research to improve this drawback of the method applying reversed phase chromatography, and as a result, they remembered that it is effective to use a specific eluent, and completed the present invention. reached. -Thus, according to the present invention, the desired length can be obtained by performing reverse phase partition chromatography from a mixture of long chain fatty acid compounds including long chain unsaturated fatty acid compounds using a column packed with a carrier for reverse phase partition chromatography. A method for separating and purifying a long-chain unsaturated fatty acid compound is provided, which is characterized in that an organic solvent having a solubility parameter of 11 to 20 is used as an eluent.

本発明で用いられる原料は、目的とする長鎖不飽和脂肪
酸化合物を含む長鎖脂肪酸化合物の混合物である。ここ
で長鎖不飽和脂肪酸化合物とは、炭素数18以上、好ま
しくは20〜22を有しかつ二重結合を3個以上有する
脂肪酸または該脂肪酸のエステル、アミドなどのごとき
誘導体を意味し、とくに低級アルキルエステルが賞月さ
れる。
The raw material used in the present invention is a mixture of long chain fatty acid compounds including the desired long chain unsaturated fatty acid compound. Here, the long-chain unsaturated fatty acid compound means a fatty acid having 18 or more carbon atoms, preferably 20 to 22 carbon atoms, and 3 or more double bonds, or a derivative such as an ester or amide of the fatty acid, and particularly Lower alkyl esters are awarded.

かかる混合物は常法に従って得ることができる。Such mixtures can be obtained according to conventional methods.

例えばイワシ、サケ、タラなどの魚類から抽出した脂質
をアルカリでケン化したのち中和することによって目的
とする長蛸不飽和脂肪酸を含む混合物を得ることができ
、該混合物をさらに常法に従ってアルコールでエステル
化することによって目的とする長鎖不飽和脂肪酸エステ
ルを含む混合物を得ることができる。また必要に応じて
得られた混合物を蒸留したり尿素包接処理を施すことに
より、目的とする成分を濃縮して用いることもできる。
For example, a mixture containing the target octopus unsaturated fatty acids can be obtained by saponifying lipids extracted from fish such as sardines, salmon, and cod with an alkali and then neutralizing them. A mixture containing the desired long-chain unsaturated fatty acid ester can be obtained by esterifying with. Further, if necessary, the target component can be concentrated and used by distilling the obtained mixture or subjecting it to urea inclusion treatment.

本発明において使用するカラム充填材は通常使用されて
いるものであればよく、その具体例としてシリカゲル系
及び高分子系のものが例示される。
The column packing material used in the present invention may be any commonly used column packing material, and specific examples thereof include silica gel-based and polymer-based ones.

前者は通常、炭素数6〜24のアルキル基をシリカに化
学結合させたもので、好しくけ炭素数8〜18のアルキ
ル基を化学結合させたものである。アルキル基はシリカ
粒子の表面にあって、溶媒との間で試料の長鎖脂肪酸化
合物を分配する機能をもち、炭素数が小さくなると試料
を保持する力が小さくなる。
The former is usually one in which an alkyl group having 6 to 24 carbon atoms is chemically bonded to silica, and preferably an alkyl group having 8 to 18 carbon atoms is chemically bonded to silica. The alkyl group is on the surface of the silica particle and has the function of distributing the long chain fatty acid compound of the sample to the solvent, and as the number of carbon atoms decreases, the ability to hold the sample decreases.

かかるシリカ充填材の粒径は通常1〜100μm。The particle size of such silica filler is usually 1 to 100 μm.

好しくけ5〜50μmであり、また粒子表面の細孔の口
径は通常20〜2ood、好しくけ50〜150Aであ
る。
The diameter is preferably 5 to 50 μm, and the diameter of the pores on the particle surface is usually 20 to 2 ood, preferably 50 to 150 Å.

一方、後者は長鎖のアルキル基または脂肪酸残基を側鎖
に有する多孔性合成高分子であり、置体的にはポリビニ
ルステアレート系、ポリオクタデシルアクリレート系、
ポリオクタデシルメタクリレート系などが例示される。
On the other hand, the latter is a porous synthetic polymer that has long-chain alkyl groups or fatty acid residues in its side chains, and its configurations include polyvinyl stearate, polyoctadecyl acrylate,
Examples include polyoctadecyl methacrylate.

本発明においては、溶離液として溶解度パラメーターδ
の値が11〜20、好ましくは12.5〜18.5の有
機溶剤を用いることが必須の要件である。ここで溶解L
パラメーターとは下式で定義されるものである。
In the present invention, the solubility parameter δ is used as the eluent.
It is essential to use an organic solvent having a value of 11 to 20, preferably 12.5 to 18.5. Here dissolve L
The parameter is defined by the following formula.

ΔE=蒸発エネルギー、U=分子容〔cIna〕用いら
れる有機溶剤の具体例としては、アセトニトリル(11
,9)、エタノール(12J9 )、エタノール(14
,5)、N−メチルホルアミド(1゜真641)、ホル
ムアミド(18,3)などがあり、分離特性、溶剤除去
の容易さなどの面でメタノールがとくに賞月される。な
お、()内の数値はδ値を表わす。
ΔE=evaporation energy, U=molecular volume [cIna] Specific examples of organic solvents used include acetonitrile (11
,9), ethanol (12J9), ethanol (14
, 5), N-methylformamide (1° true 641), and formamide (18,3), among which methanol is particularly prized for its separation properties and ease of solvent removal. Note that the numerical value in parentheses represents the δ value.

またこれらの溶剤Vi適宜混合して使用することができ
、さらにδ値が前記範囲外の溶剤であっても、混合溶剤
のδ値(それぞれの溶剤のδ値に容積分率を乗じて加算
した値)が前記範囲内にあれば本発明の範囲に包含され
る。
In addition, these solvents Vi can be appropriately mixed and used, and even if the δ value is outside the above range, the δ value of the mixed solvent (the δ value of each solvent multiplied by the volume fraction and added) If the value (value) is within the above range, it is included in the scope of the present invention.

かかる溶離液は、予め加熱還流を行い、溶存酸素を除去
しておくことが過酸化物の生成を防止するうえで好まし
い。
It is preferable to heat and reflux such an eluent in advance to remove dissolved oxygen in order to prevent the formation of peroxides.

その他の操作条件は常法に従って適宜選択することがで
きる。例えば溶離液の使用量は試料lt当り、通常50
〜10100O,好ましくはloo〜700 ml程度
であり、また溶離速度は充填剤の種類、粒度分布、細孔
径等に応じて必ずしも一定ではないが、充填層における
空1!J速度を0.05〜2゜h、−1,好ましくは0
.15〜10 hr−’にスルコトカ適切である。
Other operating conditions can be appropriately selected according to conventional methods. For example, the amount of eluent used is usually 50
~10100O, preferably about ~700ml, and the elution rate is not necessarily constant depending on the type of filler, particle size distribution, pore size, etc. J speed from 0.05 to 2゜h, -1, preferably 0
.. Surkotka is suitable for 15-10 hr-'.

かくして本発明によれば、簡単な操作で効率よく目的と
する長鎖不飽和脂肪酸化合物を精製することができる。
Thus, according to the present invention, the desired long-chain unsaturated fatty acid compound can be efficiently purified with simple operations.

以下に本発明の実施例を示すが、これによって本発明を
限定するものではない。尚、原料及び分離精製品の組成
分析はガスクロマトグラフィーを用い下記条件にて行っ
た。
Examples of the present invention are shown below, but the present invention is not limited thereto. The compositional analysis of the raw materials and separated and purified products was conducted using gas chromatography under the following conditions.

ガスクロマトグラフィーの条件 カラム: 2mX3Mφ、10%DEGS、Cel口e
545 。
Gas chromatography conditions Column: 2mX3Mφ, 10% DEGS, Cel port
545.

6G〜80mesh 渇 度: 注入口250℃、カラム200℃検出器: 
FID 実施例1 イワシ油を常法によりメチルエステル化4、メタノール
溶液下で尿素包接処理を施し、P液から高不飽和度の脂
肪酸メチルエステルを得た。1iPAメチルエステルの
i)有1は27.0%であった。この試料41を、C2
,シリル化シリカ(平均粒径38μm)300Fを充填
材とするカラム(4,1crnφX40crn)を用い
てメタノール10m4/分にて展IJN t、た。
6G~80mesh Thirst: Inlet 250℃, column 200℃Detector:
FID Example 1 Sardine oil was subjected to methyl esterification 4 by a conventional method and urea inclusion treatment in a methanol solution to obtain fatty acid methyl ester with a high degree of unsaturation from liquid P. The i) content of 1iPA methyl ester was 27.0%. This sample 41 was
, using a column (4,1crnφX40crn) packed with silylated silica (average particle size 38 μm) 300F, and expanded with methanol at 10 m4/min.

カラムからの溶出液を示差183 #?#iにより分析
したところ、第1図に示すチャートを得た。第1図中に
Aと示した両分130 mlを分取し、組成をガスクロ
ストグラフィーにて測定したところ、溶、、質662m
1Fの中0EPAエステル含有屋は99.1%であった
The eluate from the column was differentially 183 #? When analyzed using #i, the chart shown in FIG. 1 was obtained. 130 ml of both portions indicated as A in Figure 1 were collected, and the composition was measured using gas chromatography.
99.1% of the stores on the 1st floor contained 0EPA ester.

実施例2 実施例1で用いたイワシ油メチルエステルの尿素包接処
理試料4 f (hPAメチルエステル含量27.0%
、DIIAメチルエステル含量14.5%ンを、C1゜
シリル化シリカ(粒径35〜105μ) 31otを充
填したカラム(5,76nφ×30crn)を備えた大
鼠分取用高連液体クロマトグラフ〔ウォーターズ社製。
Example 2 Urea inclusion treatment sample 4 f of sardine oil methyl ester used in Example 1 (hPA methyl ester content 27.0%
, a large rat preparative high-speed liquid chromatograph equipped with a column (5,76nφ x 30crn) packed with 31 tons of C1° silylated silica (particle size 35-105μ) containing 14.5% of DIIA methyl ester. Manufactured by Waters.

Prep500A)をJ旧いてアセトニトリル/メタノ
ール(15/85、V/V )混合溶剤1 o o n
1t15k Icで展開した。
Prep500A) with acetonitrile/methanol (15/85, V/V) mixed solvent 1 o o n
It was developed with 1t15k Ic.

カラムからの溶出液を実施例1と同様にして分析したと
ころ、第2図に示すチャートが得られた。
When the eluate from the column was analyzed in the same manner as in Example 1, the chart shown in FIG. 2 was obtained.

第2図中に示す画分A及びBを分離し、これらをロータ
リー−エバポレーターにかけて溶剤を除去した結果、無
色の油状物がそれぞれ606m?、507mf得られた
。両分Aの組成はBPAメチルエステル97.5%、 
DHAメチルエステルθ%であり、画分Bの組成はDH
Aメチルエステル99.0%、 EPAメチルエステル
θ%であった。
Fractions A and B shown in Figure 2 were separated and subjected to rotary evaporation to remove the solvent, resulting in a colorless oil with 606 m? , 507 mf was obtained. The composition of both parts A is 97.5% BPA methyl ester,
DHA methyl ester θ%, and the composition of fraction B is DH
The A methyl ester content was 99.0%, and the EPA methyl ester content was θ%.

実施例3 たら肝油をエチルエステル化した試別(EPAエチルエ
ステル含有量12.0%)0.3Fを、C,シリル化シ
リカ(平均粒径5μm)309を充填材とするカラム(
1,3cn1φX72crn)を用いてホルムアミド0
、8 m47分にて展開した。カラム溶出液の示差屈D
r計によるチャートを第3図に示す。図に示すi+、!
7i分A10.5mtに水500mtを加え石油ニーデ
ル100m4で抽出した後、ロータリー9エバポレータ
ーにかけて無色油状物24.2 mWを得た。ガスクロ
マトグラフィーで調べたEPAエチルエステルの組成は
99.3%であった。
Example 3 A column containing 0.3F (EPA ethyl ester content 12.0%) prepared by ethyl esterification of cod liver oil and C, silylated silica (average particle size 5 μm) 309 as a packing material (
Formamide 0 using
, 8 m and 47 minutes. Differential bending D of column eluate
A chart based on the r meter is shown in Figure 3. i+,!
After adding 500 mt of water to 10.5 mt of 7i min A and extracting with 100 m4 of petroleum needle, the mixture was applied to a rotary 9 evaporator to obtain 24.2 mW of colorless oil. The composition of EPA ethyl ester determined by gas chromatography was 99.3%.

比較例1 展開溶媒としてメタノールの代りにジオキサン(溶解度
パラメーター10.2 )を用いること以外は実施例1
と同様にして実験を行った。その結果、示差屈折計で検
出した分離の状況は第4図に示したとおりであり、分離
は不十分であった。
Comparative Example 1 Example 1 except that dioxane (solubility parameter 10.2) was used instead of methanol as the developing solvent.
An experiment was conducted in the same manner. As a result, the state of separation detected by the differential refractometer was as shown in FIG. 4, and the separation was insufficient.

比較例2 展開溶媒としてメタノールの代りにメタノール/アセト
ン/水== 52/30/1B、 (容開化)の混合液
(溶解度パラメーター14.7)を用いること以外は実
施例1に準じて実験を行った。この溶液は試料の溶解性
に劣るため、試料4tを溶かすのに800mLを要した
。これは丁度カラム充填層容積に等しかった。そのため
カラム溶出液は第5図に示すように多成分がオーバー・
う、プしていて分離は不十分であった。
Comparative Example 2 The experiment was carried out according to Example 1, except that a mixture of methanol/acetone/water == 52/30/1B (Solubility parameter 14.7) was used as the developing solvent instead of methanol. went. Since this solution had poor sample solubility, it required 800 mL to dissolve 4 tons of sample. This was just equal to the column packing bed volume. Therefore, as shown in Figure 5, the column eluate is overloaded with multiple components.
However, the separation was insufficient.

【図面の簡単な説明】[Brief explanation of drawings]

第1図〜第3図は実施例1〜3の溶離曲線を示し、第4
図〜第5図は比較例1〜2の溶離l線を示す。 第1図 展開時間(時間) 第2図 第3図 0 1 2 3 4 展開時間(時間)
Figures 1 to 3 show the elution curves of Examples 1 to 3, and Figure 4 shows the elution curves of Examples 1 to 3.
Figures 5 to 5 show the elution I lines of Comparative Examples 1 and 2. Figure 1 Development time (hours) Figure 2 Figure 3 0 1 2 3 4 Development time (hours)

Claims (1)

【特許請求の範囲】[Claims] 1、 長鎖不飽和脂肪酸化合物を含む長鎖脂肪酸化合物
の混合物から逆相分配クロマトグラフィー用担体を充填
したカラム針用いて逆相分配クロマトグラフィーを行う
ことにより目的とする長鎖不飽和脂肪酸化合物を分離精
製する方法において、溶離液として溶′M度パラメータ
ーが11〜20の有機溶剤を用いることを特徴とする長
鎖不飽和脂肪酸化合物の分離精製法。
1. The desired long-chain unsaturated fatty acid compound is obtained from a mixture of long-chain fatty acid compounds containing the long-chain unsaturated fatty acid compound by performing reverse-phase partition chromatography using a column needle packed with a carrier for reverse-phase partition chromatography. 1. A method for separating and purifying long-chain unsaturated fatty acid compounds, characterized in that the method uses an organic solvent having a solute M degree parameter of 11 to 20 as an eluent.
JP59063892A 1984-03-31 1984-03-31 Separation and purification of long-chain saturated acid Pending JPS60208940A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59063892A JPS60208940A (en) 1984-03-31 1984-03-31 Separation and purification of long-chain saturated acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59063892A JPS60208940A (en) 1984-03-31 1984-03-31 Separation and purification of long-chain saturated acid

Publications (1)

Publication Number Publication Date
JPS60208940A true JPS60208940A (en) 1985-10-21

Family

ID=13242399

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59063892A Pending JPS60208940A (en) 1984-03-31 1984-03-31 Separation and purification of long-chain saturated acid

Country Status (1)

Country Link
JP (1) JPS60208940A (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62277496A (en) * 1986-05-27 1987-12-02 株式会社資生堂 Concentration of highly unsaturated fatty acid-containing triglyceride
JPS63312398A (en) * 1987-06-15 1988-12-20 Nisshin Oil Mills Ltd:The Production of fat and oil
JPH01294649A (en) * 1988-05-21 1989-11-28 Agency Of Ind Science & Technol Method for extracting docosahexaenoic acid and eicosapentaenoic acid in high concentration from spermary of walleye pollack
JPH0495048A (en) * 1990-08-10 1992-03-27 Shiseido Co Ltd Separation and purification of docosahexaenoic acid compound
WO1993009210A1 (en) * 1991-10-28 1993-05-13 Nippon Suisan Kaisha, Ltd. Process for producing high-purity eicosapentaenoic acid or ester thereof
JPH0633088A (en) * 1992-07-21 1994-02-08 Nippon Suisan Kaisha Ltd Production of high-purity decosahexaenoic acid or its ester
WO1998051656A1 (en) * 1997-05-12 1998-11-19 Ymc Co., Ltd. Method for the separation and purification of polyunsaturated fatty acid esters
JPH11236590A (en) * 1990-06-04 1999-08-31 Nippon Suisan Kaisha Ltd High-concentration eicosapentaenoic acid or its ester
CN102565261A (en) * 2011-12-21 2012-07-11 吉林大学 Method for detecting content of docosahexaenoic acid in egg oil
CN103293259A (en) * 2012-02-24 2013-09-11 华东理工大学 Method for analyzing composition of fatty acid in Corynebacterium glutamicum cell membrane
JP2014518388A (en) * 2011-07-06 2014-07-28 ビーエイエスエフ ファーマ(コーラニッシュ)リミテッド Heat chromatography separation method
CN104529772A (en) * 2014-12-17 2015-04-22 浙江大学 Method for preparing high-purity EPA ester and DHA ester monomers by virtue of simulated moving bed chromatography
US9234157B2 (en) 2011-07-06 2016-01-12 Basf Pharma Callanish Limited SMB process
US9260677B2 (en) 2011-07-06 2016-02-16 Basf Pharma Callanish Limited SMB process
US9315762B2 (en) 2011-07-06 2016-04-19 Basf Pharma Callanish Limited SMB process for producing highly pure EPA from fish oil
US9370730B2 (en) 2011-07-06 2016-06-21 Basf Pharma Callanish Limited SMB process
US9540306B2 (en) 2012-05-14 2017-01-10 Nippon Suisan Kaisha, Ltd. Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
US9694302B2 (en) 2013-01-09 2017-07-04 Basf Pharma (Callanish) Limited Multi-step separation process
US9790162B2 (en) 2009-12-30 2017-10-17 Basf Pharma (Callanish) Limited Simulated moving bed chromatographic separation process
US11330817B2 (en) 2013-12-04 2022-05-17 Nippon Suisan Kaisha, Ltd. Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62277496A (en) * 1986-05-27 1987-12-02 株式会社資生堂 Concentration of highly unsaturated fatty acid-containing triglyceride
JPS63312398A (en) * 1987-06-15 1988-12-20 Nisshin Oil Mills Ltd:The Production of fat and oil
JPH01294649A (en) * 1988-05-21 1989-11-28 Agency Of Ind Science & Technol Method for extracting docosahexaenoic acid and eicosapentaenoic acid in high concentration from spermary of walleye pollack
JPH11236590A (en) * 1990-06-04 1999-08-31 Nippon Suisan Kaisha Ltd High-concentration eicosapentaenoic acid or its ester
JPH0495048A (en) * 1990-08-10 1992-03-27 Shiseido Co Ltd Separation and purification of docosahexaenoic acid compound
JPH0813776B2 (en) * 1990-08-10 1996-02-14 株式会社資生堂 Method for separating and purifying docosahexaenoic acid compound
AU664866B2 (en) * 1991-10-28 1995-12-07 Nippon Suisan Kaisha, Ltd. Process for producing high-purity eicosapentaenoic acid or ester thereof
US5840944A (en) * 1991-10-28 1998-11-24 Nippon Suisan Kaisha, Ltd. Method to produce highly pure eicosapentaenoic acid or its ester
WO1993009210A1 (en) * 1991-10-28 1993-05-13 Nippon Suisan Kaisha, Ltd. Process for producing high-purity eicosapentaenoic acid or ester thereof
JPH0633088A (en) * 1992-07-21 1994-02-08 Nippon Suisan Kaisha Ltd Production of high-purity decosahexaenoic acid or its ester
WO1998051656A1 (en) * 1997-05-12 1998-11-19 Ymc Co., Ltd. Method for the separation and purification of polyunsaturated fatty acid esters
JP2019108340A (en) * 2009-12-30 2019-07-04 ビーエイエスエフ ファーマ(コーラニッシュ)リミテッド Simulated moving bed chromatographic separation process
US9790162B2 (en) 2009-12-30 2017-10-17 Basf Pharma (Callanish) Limited Simulated moving bed chromatographic separation process
US9347020B2 (en) 2011-07-06 2016-05-24 Basf Pharma Callanish Limited Heated chromatographic separation process
US9771542B2 (en) 2011-07-06 2017-09-26 Basf Pharma Callanish Ltd. Heated chromatographic separation process
US9234157B2 (en) 2011-07-06 2016-01-12 Basf Pharma Callanish Limited SMB process
US9260677B2 (en) 2011-07-06 2016-02-16 Basf Pharma Callanish Limited SMB process
US9315762B2 (en) 2011-07-06 2016-04-19 Basf Pharma Callanish Limited SMB process for producing highly pure EPA from fish oil
JP2014518388A (en) * 2011-07-06 2014-07-28 ビーエイエスエフ ファーマ(コーラニッシュ)リミテッド Heat chromatography separation method
US9370730B2 (en) 2011-07-06 2016-06-21 Basf Pharma Callanish Limited SMB process
KR20180033599A (en) * 2011-07-06 2018-04-03 바스프 파마 (칼라니쉬) 리미티드 Heated chromatographic separation process
US9695382B2 (en) 2011-07-06 2017-07-04 Basf Pharma (Callanish) Limited SMB process for producing highly pure EPA from fish oil
CN102565261A (en) * 2011-12-21 2012-07-11 吉林大学 Method for detecting content of docosahexaenoic acid in egg oil
CN103293259A (en) * 2012-02-24 2013-09-11 华东理工大学 Method for analyzing composition of fatty acid in Corynebacterium glutamicum cell membrane
US9540306B2 (en) 2012-05-14 2017-01-10 Nippon Suisan Kaisha, Ltd. Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
US10399922B2 (en) 2012-05-14 2019-09-03 Nippon Suisan Kaisha, Ltd. Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
US10399923B2 (en) 2012-05-14 2019-09-03 Nippon Suisan Kaisha, Ltd. Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
US11034643B2 (en) 2012-05-14 2021-06-15 Nippon Suisan Kaisha, Ltd. Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
US11603347B2 (en) 2012-05-14 2023-03-14 Nippon Suisan Kaisha, Ltd. Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
US9694302B2 (en) 2013-01-09 2017-07-04 Basf Pharma (Callanish) Limited Multi-step separation process
US10179759B2 (en) 2013-01-09 2019-01-15 Basf Pharma (Callanish) Limited Multi-step separation process
US10214475B2 (en) 2013-01-09 2019-02-26 Basf Pharma (Callanish) Limited Multi-step separation process
US10723973B2 (en) 2013-01-09 2020-07-28 Basf Pharma (Callanish) Limited Multi-step separation process
US11330817B2 (en) 2013-12-04 2022-05-17 Nippon Suisan Kaisha, Ltd. Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil
US11856952B2 (en) 2013-12-04 2024-01-02 Nippon Suisan Kaisha, Ltd. Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil
CN104529772A (en) * 2014-12-17 2015-04-22 浙江大学 Method for preparing high-purity EPA ester and DHA ester monomers by virtue of simulated moving bed chromatography

Similar Documents

Publication Publication Date Title
JPS60208940A (en) Separation and purification of long-chain saturated acid
US6395778B1 (en) Process for making an enriched mixture of polyunsaturated fatty acid esters
US7541480B2 (en) Process for the preparation of a composition comprising unsaturated compounds
EP1065196B1 (en) Process of selectively separating and purifying eicosapentaenoic and docosahexaenoic acids or their esters
EP0178442B1 (en) Process for the selective enrichment of a delta-6 and delta-9 fatty acids containing mixture with delta-6 polyunsaturated fatty acids, the enriched fractions thus obtained and their use
EP0682006B1 (en) Process for the preparation of a concentrate of esters of polyunsaturated fatty acids
Youngs Determination of the glyceride structure of fats
JPH0159318B2 (en)
JPS63185390A (en) Production of eicosapentaenoic acid by algae
EP2970820B1 (en) Recovering urea and oil from a urea/oil complex
JPH0225447A (en) Production of highly unsaturated fatty acids
JPS649977B2 (en)
CA2822314A1 (en) Concentrate of omega 3
US5734071A (en) Process for separating lipophilic compounds
Quinn et al. Synthesis of 100-gram quantities of highly purified mixed acid triglycerides
JP3001954B2 (en) How to obtain polyunsaturated fatty acids
JPS58165796A (en) Concentration of long chain highly unsaturated fatty acid glyceride
JP2786748B2 (en) Purification method of polyunsaturated fatty acids
JP2935555B2 (en) Separation and purification of polyunsaturated fatty acids
JPH09151390A (en) Purification of highly unsaturated fatty acid and its derivative
US3405151A (en) Chromatographic separation of gamma-linolenic acid esters
JP3880095B2 (en) Method for purifying highly unsaturated fatty acids
JP2001240893A (en) Method of purifying eiosapentaenoic acid or its derivative
JPH0768169B2 (en) Method for separating eicosapentaenoic acid ester and / or docosahexaenoic acid ester
Iskhakov et al. The fatty acid composition of the phospholipids of cottonseed oil